Literature DB >> 4985288

Diabetic ketoacidosis. A review of cases at a university medical center.

J F Kiraly, C E Becker, H E Williams.   

Abstract

Twenty-five cases of diabetic ketoacidosis were studied retrospectively with respect to clinical characteristics and results of therapy. In this series (as with all 88 patients admitted in the last five years with a diagnosis of diabetic ketoacidosis) there were no deaths. Infection was found to be the most common precipitating event, documented by physical findings and cultures in one-third of these cases. In about two-thirds of the cases, electrocardiograms which were read as abnormal on admission reverted to normal after therapy. In all patients serum potassium levels decreased from admission values; one patient became symptomatically hypokalemic. Low serum potassium levels on admission and early vigorous bicarbonate therapy are emphasized as major predisposing factors of symptomatic hypokalemia. None of the patients had overt hyperosmolar coma, lactic acidosis or cerebral edema during therapy.

Entities:  

Mesh:

Year:  1970        PMID: 4985288      PMCID: PMC1501337     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  15 in total

1.  INTRAVENTRICULAR CONDUCTION DEFECT AND RESPIRATORY TRACT PARALYSIS IN DIABETIC KETOACIDOSIS.

Authors:  D S FISCHER; B A NICHOL
Journal:  Am J Med       Date:  1963-07       Impact factor: 4.965

2.  Diabetic acidosis; results of treatment in 67 consecutive cases.

Authors:  R HARWOOD
Journal:  N Engl J Med       Date:  1951-07-05       Impact factor: 91.245

3.  Medical staff conference. Hyperosmolar non-ketotic diabetes.

Authors: 
Journal:  Calif Med       Date:  1967-02

4.  Intensive intravenous potassium replacement therapy.

Authors:  H Pullen; A Doig; A T Lambie
Journal:  Lancet       Date:  1967-10-14       Impact factor: 79.321

5.  Extreme hypokalemia during treatment of diabetic ketoacidosis.

Authors:  S S Bergen
Journal:  N Y State J Med       Date:  1967-08-15

6.  Cerebral edema with irreversible coma in severe diabetic ketoacidosis.

Authors:  E Young; R F Bradley
Journal:  N Engl J Med       Date:  1967-03-23       Impact factor: 91.245

7.  Early and intensive potassium replacement in diabetic acidosis.

Authors:  H C Seftel; M C Kew
Journal:  Diabetes       Date:  1966-09       Impact factor: 9.461

8.  Medical staff conference. Lactic acidosis.

Authors:  M J Cline; H E Williams; L H Smith
Journal:  Calif Med       Date:  1969-04

9.  Diabetic acidosis with initial hypokalemia. Therapeutic implications.

Authors:  E Abramson; R Arky
Journal:  JAMA       Date:  1966-05-02       Impact factor: 56.272

10.  Creatininemia versus uremia. The relative significance of blood urea nitrogen and serum creatinine concentrations in azotemia.

Authors:  J B Dossetor
Journal:  Ann Intern Med       Date:  1966-12       Impact factor: 25.391

View more
  12 in total

1.  Thiazides and hypokalaemia in diabetic ketoacidosis.

Authors:  K G Alberti; T D Hockaday
Journal:  Postgrad Med J       Date:  1973-01       Impact factor: 2.401

Review 2.  Preventing Diabetes and Atherosclerosis in the Cardiometabolic Syndrome.

Authors:  Muhammad Imtiaz Ahmad; Michael D Shapiro
Journal:  Curr Atheroscler Rep       Date:  2021-03-09       Impact factor: 5.113

Review 3.  Diabetes, Lipids, and CV Risk.

Authors:  Jan Škrha
Journal:  Curr Atheroscler Rep       Date:  2021-01-19       Impact factor: 5.113

Review 4.  SGLT2 Inhibitors: Benefits for CKD and Cardiovascular Disease in Type 2 Diabetes.

Authors:  Rohit Singhal; Lisa Aimee Hechanova
Journal:  Curr Cardiol Rep       Date:  2022-02-11       Impact factor: 2.931

Review 5.  Obesity Management in Cardiometabolic Disease: State of the Art.

Authors:  Sean J Iwamoto; Layla A Abushamat; Adnin Zaman; Anthony J Millard; Marc-Andre Cornier
Journal:  Curr Atheroscler Rep       Date:  2021-08-04       Impact factor: 5.113

Review 6.  Respiratory failure in diabetic ketoacidosis.

Authors:  Nikifor K Konstantinov; Mark Rohrscheib; Emmanuel I Agaba; Richard I Dorin; Glen H Murata; Antonios H Tzamaloukas
Journal:  World J Diabetes       Date:  2015-07-25

7.  Efficacy and safety of generic exenatide injection in Chinese patients with type 2 diabetes: a multicenter, randomized, controlled, non-inferiority trial.

Authors:  Jin Yang; Wenhua Xiao; Lixin Guo; Quanmin Li; Liyong Zhong; Jinkui Yang; Jing Yang; Yongyi Gao; Qing Tian; Tianpei Hong
Journal:  Acta Diabetol       Date:  2020-03-23       Impact factor: 4.280

Review 8.  Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence.

Authors:  Yi Tan; Zhiguo Zhang; Chao Zheng; Kupper A Wintergerst; Bradley B Keller; Lu Cai
Journal:  Nat Rev Cardiol       Date:  2020-02-20       Impact factor: 32.419

9.  Effects of Liraglutide on Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Authors:  Tiantian Song; Yujiao Jia; Zelin Li; Fei Wang; Luping Ren; Shuchun Chen
Journal:  Diabetes Ther       Date:  2021-05-17       Impact factor: 2.945

10.  The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes.

Authors:  Suvanjaa Sivalingam; Emil List Larsen; Daniel H van Raalte; Marcel H A Muskiet; Mark M Smits; Lennart Tonneijck; Jaap A Joles; Bernt Johan von Scholten; Emilie Hein Zobel; Frederik Persson; Trine Henriksen; Lars Jorge Diaz; Tine W Hansen; Henrik Enghusen Poulsen; Peter Rossing
Journal:  Sci Rep       Date:  2021-05-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.